Leit í EES-gagnagrunni
Regulation (EU) 2017/1001 of the European Parliament and of the Council of 14 June 2017 on the European Union trade mark
COM(2016) 596
Directive (EU) 2017/1564 of the European Parliament and of the Council of 13 September 2017 on certain permitted uses of certain works and other subject matter protected by copyright and related rights for the benefit of persons who are blind, visually impaired or otherwise print-disabled and amending Directive 2001/29/EC on the harmonisation of certain aspects of copyright and related rights in the information society
Tilskipun Evrópuþingsins og ráðsins (ESB) 2017/1564 frá 13. september 2017 um tiltekna leyfilega notkun á tilteknum verkum og öðru efni sem er verndað af höfundarrétti og skyldum réttindum í þágu blindra, sjónskertra eða þeirra sem glíma við aðra prentleturshömlun og um breytingu á tilskipun 2001/29/EB um samræmingu tiltekinna þátta höfundaréttar og skyldra réttinda í upplýsingasamfélaginu
COM(2015) 627
Regulation (EU) 2017/1128 of the European Parliament and of the Council of 14 June 2017 on cross-border portability of online content services in the internal market
Reglugerð Evrópuþingsins og ráðsins (ESB) 2017/1128 frá 14. júní 2017 um flytjanleika efnisveituþjónustu á Netinu yfir landamæri á innri markaðnum
Directive 2006/116/EC of the European Parliament and of the Council of 12 December 2006 on the term of protection of copyright and certain related rights
Tilskipun Evrópuþingsins og ráðsins 2006/116/EB frá 12. desember 2006 um verndartíma höfundarréttar og tiltekinna, skyldra réttinda
Directive 2006/115/EC of the European Parliament and of the Council of 12 December 2006 on rental right and lending right and on certain rights related to copyright in the field of intellectual property
Tilskipun Evrópuþingsins og ráðsins 2006/115/EB frá 12. desember 2006 um leigu- og útlánsrétt og önnur tiltekin réttindi, tengd höfundarrétti, á sviði hugverkaréttar
Regulation (EC) No 816/2006 of the European Parliament and of the Council of 17 May 2006 on compulsory licensing of patents relating to the manufacture of pharmaceutical products for export to countries with public health problems